JP2001335593A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2001335593A5 JP2001335593A5 JP2000137975A JP2000137975A JP2001335593A5 JP 2001335593 A5 JP2001335593 A5 JP 2001335593A5 JP 2000137975 A JP2000137975 A JP 2000137975A JP 2000137975 A JP2000137975 A JP 2000137975A JP 2001335593 A5 JP2001335593 A5 JP 2001335593A5
- Authority
- JP
- Japan
- Prior art keywords
- group
- compound according
- cytosine
- ethynylpyrimidine
- ethynyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2000137975A JP4039790B2 (ja) | 1999-05-12 | 2000-05-11 | ４’−ｃ−エチニルピリミジンヌクレオシド化合物 |
Applications Claiming Priority (9)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP13153999 | 1999-05-12 | ||
| JP17492099 | 1999-06-22 | ||
| JP31824699 | 1999-11-09 | ||
| JP11-174920 | 2000-03-23 | ||
| JP2000-81117 | 2000-03-23 | ||
| JP11-318246 | 2000-03-23 | ||
| JP2000081117 | 2000-03-23 | ||
| JP11-131539 | 2000-03-23 | ||
| JP2000137975A JP4039790B2 (ja) | 1999-05-12 | 2000-05-11 | ４’−ｃ−エチニルピリミジンヌクレオシド化合物 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2001335593A JP2001335593A (ja) | 2001-12-04 |
| JP2001335593A5 true JP2001335593A5 (https=) | 2007-08-30 |
| JP4039790B2 JP4039790B2 (ja) | 2008-01-30 |
Family
ID=27527274
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2000137975A Expired - Lifetime JP4039790B2 (ja) | 1999-05-12 | 2000-05-11 | ４’−ｃ−エチニルピリミジンヌクレオシド化合物 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP4039790B2 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE602005015466D1 (de) * | 2004-08-23 | 2009-08-27 | Hoffmann La Roche | Antivirale 4'-azidonucleoside |
| US10933067B2 (en) | 2016-11-16 | 2021-03-02 | National Center For Global Health And Medicine | Nucleoside derivative having physiological activity such as antiviral activity |
| JP7025064B2 (ja) * | 2018-08-09 | 2022-02-24 | ヤマサ醤油株式会社 | ４’－置換ヌクレオシド誘導体の立体選択的合成法 |
| US20220177509A1 (en) * | 2019-04-05 | 2022-06-09 | Nippon Shokubai Co., Ltd. | Production of bridged artificial nucleosides |
-
2000
- 2000-05-11 JP JP2000137975A patent/JP4039790B2/ja not_active Expired - Lifetime
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR0011521A (pt) | Composto nucleósidos de purina de 4' -c-etinila | |
| JPH11193282A5 (https=) | ||
| CA2470255A1 (en) | N4-acylcytosine nucleosides for treatment of viral infections | |
| JP2020512302A5 (https=) | ||
| JP2002534523A5 (https=) | ||
| JP2005525991A5 (https=) | ||
| JP2008505902A5 (https=) | ||
| JP2008523098A5 (https=) | ||
| JP2004509061A5 (https=) | ||
| JP2002508352A5 (ja) | ４(３)置換−４(３)−アミノメチル−（チオ）ピラン又はピペリジン誘導体（＝ガバペンチン類似体） | |
| HUP0202593A2 (hu) | Reverz transzkriptáz inhibitor hatású benzofenonok és ilyen vegyületeket tartalmazó gyógyászati készítmények | |
| JP2007534636A5 (https=) | ||
| JP2002525323A5 (https=) | ||
| RU2002100058A (ru) | Кристаллические производные 1-метилкарбапенема | |
| JP2003520783A5 (https=) | ||
| JP2003534359A5 (https=) | ||
| JP2008069182A5 (https=) | ||
| JP2005526773A5 (https=) | ||
| JP2001335593A5 (https=) | ||
| JP2002522386A5 (https=) | ||
| CA2287370A1 (en) | Synthesis, anti-human immunodeficiency virus and anti-hepatitis b virus activities of 1,3-oxaselenolane nucleosides | |
| HUP9800865A2 (hu) | Kondenzált piperidinszármazékok, eljárás előállításukra és ezeket a vegyületeket tartalmazó gyógyszerkészítmények | |
| JP2001335592A5 (https=) | ||
| JP2002522385A5 (https=) | ||
| WO2004029064A8 (en) | (+)-trans-isomers of (1-phosphonomethoxy-2-alkylcyclopropyl) methyl nucleoside derivatives, process for the preparation of stereoisomers thereof, and use of antiviral agents thereof |